112 related articles for article (PubMed ID: 23757389)
1. A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project.
Correr CJ; Melchiors AC; de Souza TT; Rotta I; Salgado TM; Fernandez-Llimos F
Ann Pharmacother; 2013; 47(7-8):946-52. PubMed ID: 23757389
[TBL] [Abstract][Full Text] [Related]
2. Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT.
Rotta I; Salgado TM; Felix DC; Souza TT; Correr CJ; Fernandez-Llimos F
J Eval Clin Pract; 2015 Aug; 21(4):584-90. PubMed ID: 25676042
[TBL] [Abstract][Full Text] [Related]
3. Assessing the implementability of clinical pharmacist interventions in patients with chronic kidney disease: an analysis of systematic reviews.
Salgado TM; Correr CJ; Moles R; Benrimoj SI; Fernandez-Llimos F
Ann Pharmacother; 2013 Nov; 47(11):1498-506. PubMed ID: 24259596
[TBL] [Abstract][Full Text] [Related]
4. Development and reliability testing of the clinical pharmacist recommendation taxonomy.
Hoth AB; Carter BL; Ness J; Bhattacharyya A; Shorr RI; Rosenthal GE; Kaboli PJ
Pharmacotherapy; 2007 May; 27(5):639-46. PubMed ID: 17461698
[TBL] [Abstract][Full Text] [Related]
5. Drug errors and related interventions reported by United States clinical pharmacists: the American College of Clinical Pharmacy practice-based research network medication error detection, amelioration and prevention study.
Kuo GM; Touchette DR; Marinac JS
Pharmacotherapy; 2013 Mar; 33(3):253-65. PubMed ID: 23378169
[TBL] [Abstract][Full Text] [Related]
6. Impact of clinical pharmacy services on patients in an outpatient chemotherapy academic clinic.
McKee M; Frei BL; Garcia A; Fike D; Soefje SA
J Oncol Pharm Pract; 2011 Dec; 17(4):387-94. PubMed ID: 21239453
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature.
Gallagher J; McCarthy S; Byrne S
Int J Clin Pharm; 2014 Dec; 36(6):1101-14. PubMed ID: 25218003
[TBL] [Abstract][Full Text] [Related]
8. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
MacLaren R; Bond CA
Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
[TBL] [Abstract][Full Text] [Related]
9. Agreement between pharmacists for problem identification: an initial quality measurement of cognitive services.
LaFleur J; Larson BS; Gunning KM; Stoddard GJ; Madden C; Oderda L; Steinvoort C; Oderda GM
Ann Pharmacother; 2009 Jul; 43(7):1173-80. PubMed ID: 19584393
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S
Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928
[TBL] [Abstract][Full Text] [Related]
11. Usability and sensitivity of the risk of bias assessment tool for randomized controlled trials of pharmacist interventions.
Tonin FS; Lopes LA; Rotta I; Bonetti AF; Pontarolo R; Correr CJ; Fernandez-Llimos F
Int J Clin Pharm; 2019 Jun; 41(3):785-792. PubMed ID: 30963446
[TBL] [Abstract][Full Text] [Related]
12. Assessment of methodologic quality of randomized trials of interventional techniques: development of an interventional pain management specific instrument.
Manchikanti L; Hirsch JA; Cohen SP; Heavner JE; Falco FJ; Diwan S; Boswell MV; Candido KD; Onyewu CO; Zhu J; Sehgal N; Kaye AD; Benyamin RM; Helm S; Singh V; Datta S; Abdi S; Christo PJ; Hameed H; Hameed M; Vallejo R; Pampati V; Racz GB; Raj PP
Pain Physician; 2014; 17(3):E263-90. PubMed ID: 24850111
[TBL] [Abstract][Full Text] [Related]
13. Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center.
Tuffaha HW; Koopmans SM
J Oncol Pharm Pract; 2012 Jun; 18(2):180-5. PubMed ID: 21862687
[TBL] [Abstract][Full Text] [Related]
14. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000-2010).
Rotta I; Salgado TM; Silva ML; Correr CJ; Fernandez-Llimos F
Int J Clin Pharm; 2015 Oct; 37(5):687-97. PubMed ID: 26001356
[TBL] [Abstract][Full Text] [Related]
16. Acute care clinical pharmacy practice: unit- versus service-based models.
; Haas CE; Eckel S; Arif S; Beringer PM; Blake EW; Lardieri AB; Lobo BL; Mercer JM; Moye P; Orlando PL; Wargo K
Pharmacotherapy; 2012 Feb; 32(2):e35-44. PubMed ID: 22392430
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review.
Stemer G; Lemmens-Gruber R
BMC Nephrol; 2011 Jul; 12():35. PubMed ID: 21777480
[TBL] [Abstract][Full Text] [Related]
18. Practical, reliable, comprehensive method for characterizing pharmacists' clinical activities.
Overhage JM; Lukes A
Am J Health Syst Pharm; 1999 Dec; 56(23):2444-50. PubMed ID: 10595804
[TBL] [Abstract][Full Text] [Related]
19. Impact of clinical pharmacists in outpatient oncology practices: A review.
Gatwood J; Gatwood K; Gabre E; Alexander M
Am J Health Syst Pharm; 2017 Oct; 74(19):1549-1557. PubMed ID: 28947527
[TBL] [Abstract][Full Text] [Related]
20. Estimates of quality and reliability with the physiotherapy evidence-based database scale to assess the methodology of randomized controlled trials of pharmacological and nonpharmacological interventions.
Foley NC; Bhogal SK; Teasell RW; Bureau Y; Speechley MR
Phys Ther; 2006 Jun; 86(6):817-24. PubMed ID: 16737407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
